All Type of News
Negotiation with KMA to be delayed to mid-December
The health ministry’s committee on medical reform Thursday decided to finalize the 2013 medical service fee on doctor in the middle of December as the Korean Medical Association defied any negotiation over the issue.
...
Medical bills for ultrasonograms, tooth scaling will go down
The costs that individuals will have to shoulder for ultrasonograms and tooth scaling will go down from next year,
The measure, approved at a meeting of the ministry’s committee on medical reform on Thursday, is a...
Health insurance fee to rise 1.6%
The Ministry of Health and Welfare said Thursday it will raise health insurance premiums by 1.6 percent beginning next year.
Under the ministry's plan, individual subscribers and workplace subscribers must pay an a...
KPMA to toughen punishment for dumping
The Korea Pharmaceutical Manufacturers Association on Wednesday announced a set of measures to toughen the predatory pricing, commonly referred to as “dumping,” to strengthen preventive measures to root out such irreg...
Korean companies struggling to find new growth engines
The government’s forced price cuts for drugs and other medical products covered by National Health Insurance in April has dealt a blow to local pharmaceutical firms.
To cope with a host of unfavorable business cond...
Health minister affirms new prescription plan needs doctors’ consensus
Health and Welfare Minister Rim Che-min indicated Wednesday that the new prescription plan requires doctors’ consensus.
Under the new plan, medical doctors will have to make prescriptions listing only chemical ingr...
KFDA approves 10 Baraclude generics
Ten Korean pharmaceutical firms, including CJ Pharm, SK Chemicals and Hanmi Pharm, are allowed to produce generic versions of the hepatitis B drug Baraclude, the Korea Food and Drug Administration officials said Thurs...
Hyundai, Takeda team up for TachoSil patch
Hyundai Pharm announced Wednesday that it has signed an agreement with Takeda Pharmaceuticals Korea for the exclusive distribution right in Korea of TachoSil (absorbable fibrin sealant patch) for use as an adjunct to ...
29 Korean companies sign deal to transfer formulation technologies to 26 foreign countries
A total of 91 formulation technologies have been transferred by 29 Korean pharmaceutical firms to 26 foreign drug manufacturers since Hanmi Pharm exported the formulation technology of ceftriaxone to Swiss based Roche...
Dong-A Pharm to split into two operating entities
Dong-A Pharm Co., a Korea’s largest drugmaker, said Tuesday that it will split into two operating entities to simplify its corporate structure and boost investor interest.
A board of directors finalized the plan on...
